T helper 1 cell (Th1 cell)

T helper 1 (Th1) cells are a subtype of CD4+ T lymphocytes that play a central role in adaptive immunity, particularly in protecting against intracellular pathogens such as viruses and certain bacteria. Upon encounter with antigen-presenting cells (APCs) and exposure to cytokines IL-12 and IFN-γ, naïve CD4+ T cells differentiate into Th1 cells, marked by expression of the master regulator T-bet and secretion of cytokines such as IFN-γ and TNF-α. Th1 cells promote the activation of macrophages, enhance cytotoxic T lymphocyte (CTL) responses, and stimulate the production of opsonizing and complement-fixing antibodies. Overactivation or dysregulation of Th1 responses can contribute to inflammatory and autoimmune diseases[1][3][5][7]. Key context and clarification: - “T helper 1 cell activation” is not a *protein, receptor, enzyme, transporter,* or single molecule, so it should not be considered a canonical therapeutic target as typically defined in drug discovery[1][5][7]. - Direct drug targeting of “T helper 1 cell activation” does not occur; rather, drug strategies may aim to suppress or modulate Th1 differentiation or function by targeting upstream cytokines (IL-12, IFN-γ), downstream mediators, or co-stimulatory/inhibitory molecules on immune cells. Summary: T helper 1 cell activation is a cellular immune process, not a molecular or receptor target. Thus, this entry is incorrect under classical target nomenclature systems used for drug discovery or structured biological target classification[1][3][5][7].

Other names

Th1 lymphocyteType 1 helper T cellCD4+ Th1 cell